162 related articles for article (PubMed ID: 36932973)
21. Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application.
Wei R; Dean DC; Thanindratarn P; Hornicek FJ; Guo W; Duan Z
Cancer Lett; 2020 Jun; 479():54-60. PubMed ID: 31634526
[TBL] [Abstract][Full Text] [Related]
22. Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation.
Kang J; Lee HJ; Jun SY; Park ES; Maeng LS
PLoS One; 2015; 10(9):e0137476. PubMed ID: 26360551
[TBL] [Abstract][Full Text] [Related]
23. Integrative discovery of epigenetically derepressed cancer testis antigens in NSCLC.
Glazer CA; Smith IM; Ochs MF; Begum S; Westra W; Chang SS; Sun W; Bhan S; Khan Z; Ahrendt S; Califano JA
PLoS One; 2009 Dec; 4(12):e8189. PubMed ID: 19997593
[TBL] [Abstract][Full Text] [Related]
24. Cancer/testis antigens: from serology to mRNA cancer vaccine.
Fan C; Qu H; Wang X; Sobhani N; Wang L; Liu S; Xiong W; Zeng Z; Li Y
Semin Cancer Biol; 2021 Nov; 76():218-231. PubMed ID: 33910064
[TBL] [Abstract][Full Text] [Related]
25. Cancer/Testis Antigen MAGE-C1/CT7: new target for multiple myeloma therapy.
de Carvalho F; Vettore AL; Colleoni GW
Clin Dev Immunol; 2012; 2012():257695. PubMed ID: 22481966
[TBL] [Abstract][Full Text] [Related]
26. Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy.
Shim K; Jo H; Jeoung D
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834126
[TBL] [Abstract][Full Text] [Related]
27. The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma.
Natsume A; Wakabayashi T; Tsujimura K; Shimato S; Ito M; Kuzushima K; Kondo Y; Sekido Y; Kawatsura H; Narita Y; Yoshida J
Int J Cancer; 2008 Jun; 122(11):2542-53. PubMed ID: 18240144
[TBL] [Abstract][Full Text] [Related]
28. Cancer/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cells.
Yang P; Huo Z; Liao H; Zhou Q
Curr Pharm Des; 2015; 21(10):1292-300. PubMed ID: 25506890
[TBL] [Abstract][Full Text] [Related]
29. Cancer/Testis Antigens into mitochondria: a hub between spermatogenesis, tumorigenesis and mitochondrial physiology adaptation.
Aurrière J; Goudenège D; Baris OR; Boguenet M; May-Panloup P; Lenaers G; Khiati S
Mitochondrion; 2021 Jan; 56():73-81. PubMed ID: 33220498
[TBL] [Abstract][Full Text] [Related]
30. Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips.
Naumov VA; Generozov EV; Zaharjevskaya NB; Matushkina DS; Larin AK; Chernyshov SV; Alekseev MV; Shelygin YA; Govorun VM
Epigenetics; 2013 Sep; 8(9):921-34. PubMed ID: 23867710
[TBL] [Abstract][Full Text] [Related]
31. The therapeutic potential value of Cancer-testis antigens in immunotherapy of gastric cancer.
Alsadat Mahmoudian R; Amirhosein M; Mahmoudian P; Fardi Golyan F; Mokhlessi L; Maftooh M; Khazaei M; Nassiri M; Mahdi Hassanian S; Ghayour-Mobarhan M; Ferns GA; Shahidsales S; Avan A
Gene; 2023 Feb; 853():147082. PubMed ID: 36464170
[TBL] [Abstract][Full Text] [Related]
32. Leveraging epigenetics to enhance the efficacy of cancer-testis antigen: a potential candidate for immunotherapy.
Gupta R; Jit BP; Kumar S; Mittan S; Tanwer P; Ray MD; Mathur S; Perumal V; Kumar L; Rath GK; Sharma A
Epigenomics; 2022 Jul; 14(14):865-886. PubMed ID: 35872653
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
34. A novel era of cancer/testis antigen in cancer immunotherapy.
Meng X; Sun X; Liu Z; He Y
Int Immunopharmacol; 2021 Sep; 98():107889. PubMed ID: 34174699
[TBL] [Abstract][Full Text] [Related]
35. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
36. Expression of cancer-testis antigens in the immune microenvironment of non-small cell lung cancer.
Hikmet F; Rassy M; Backman M; Méar L; Mattsson JSM; Djureinovic D; Botling J; Brunnström H; Micke P; Lindskog C
Mol Oncol; 2023 Dec; 17(12):2603-2617. PubMed ID: 37341056
[TBL] [Abstract][Full Text] [Related]
37. Expression of Cancer-Testis Antigens in Pediatric Cancers.
Ghafouri-Fard S
Asian Pac J Cancer Prev; 2015; 16(13):5149-52. PubMed ID: 26225644
[TBL] [Abstract][Full Text] [Related]
38. Roles of cancer/testis antigens (CTAs) in breast cancer.
Li Y; Li J; Wang Y; Zhang Y; Chu J; Sun C; Fu Z; Huang Y; Zhang H; Yuan H; Yin Y
Cancer Lett; 2017 Jul; 399():64-73. PubMed ID: 28274891
[TBL] [Abstract][Full Text] [Related]
39. Multiple sporadic colorectal cancers display a unique methylation phenotype.
Gonzalo V; Lozano JJ; Alonso-Espinaco V; Moreira L; Muñoz J; Pellisé M; Castellví-Bel S; Bessa X; Andreu M; Xicola RM; Llor X; Ruiz-Ponte C; Carracedo A; Jover R; Castells A; Balaguer F;
PLoS One; 2014; 9(3):e91033. PubMed ID: 24643221
[TBL] [Abstract][Full Text] [Related]
40. Cancer/testis antigens and urological malignancies.
Kulkarni P; Shiraishi T; Rajagopalan K; Kim R; Mooney SM; Getzenberg RH
Nat Rev Urol; 2012 Jun; 9(7):386-96. PubMed ID: 22710665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]